Atlas Trials

NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer

Clinical trial NCT01931163 · COMPLETED

Trial details

NCT number
NCT01931163
Sponsor
Jenny C. Chang, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerTriple Negative Breast Cancer
Start date
2013-07-01
Primary completion
2019-01-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.